Rucker Michael A. 4
4 · Pediatrix Medical Group, Inc. · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
Pediatrix (MD) Director Michael A. Rucker Receives Award
What Happened Michael A. Rucker, a director of Pediatrix Medical Group, was granted 7,196 restricted shares on May 7, 2026. The award was granted at $0.00 per share (an equity grant, not a purchase), so no cash was paid on acquisition.
Key Details
- Transaction date: 2026-05-07; Form 4 filed: 2026-05-11 (filed within the SEC two-business-day deadline).
- Transaction type/code: Award/Grant (A).
- Shares received: 7,196 restricted shares; acquisition price reported as $0.00.
- Vesting: Shares will vest on May 7, 2027 (per filing footnote under the 2008 Incentive Compensation Plan).
- Shares owned after transaction: Not specified in the provided excerpt.
- Not a 10% owner transaction; no sale or exercise reported.
Context This was an annual equity award under the issuer’s Amended and Restated 2008 Incentive Compensation Plan. Restricted-share grants are a common form of director compensation; they represent future equity subject to vesting and are not the same as an open-market purchase or sale.
Insider Transaction Report
Form 4
Rucker Michael A.
Director
Transactions
- Award
Common Stock
[F1]2026-05-07+7,196→ 66,297 total
Footnotes (1)
- [F1]Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.
Signature
Mary Ann E. Moore, Attorney-in-Fact|2026-05-11